Swedish Hospital Installs SyMRI Neuro for Improved Followup of MS Patients

first_img News | Magnetic Resonance Imaging (MRI) | August 06, 2019 Canon Medical Introduces Encore Orian MR Upgrade Program Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch… read more September 2, 2015 — Linköping University Hospital in Sweden has installed SyMRI Neuro from SyntheticMR in order to improve the follow-up of patients with multiple sclerosis (MS). SyMRI enables objective follow-up of brain atrophy through automatic calculation of brain parenchymal fraction (BPF). After an initial pilot project, the aim is to take SyMRI into clinical use in Region Östergötland during 2016.Magnetic resonance imaging (MRI) is especially good at visualizing soft tissue in the body and is used in the investigation and monitoring of MS. With current methods, however, physicians are for the most part forced to make subjective judgments of the images, which can make it difficult to obtain a good and comparable measure of disease development.“With SyMRI we can get an automatic measurement of brain atrophy, which means that we can now quantify the neurodegeneration that occurs in connection with MS. This allows for a better follow-up for our patients”, said Patrik Fägerstam, M.D., neuroradiologist at Linköping University Hospital.SyMRI Neuro will be installed in the hospital’s picture archiving and communication system (PACS) from Sectra.For more information: www.symri.com FacebookTwitterLinkedInPrint分享 Technology | Neuro Imaging | August 07, 2019 Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release… read more News | Image Guided Radiation Therapy (IGRT) | July 16, 2019 AAPM 2019 Features More Than 40 Presentations on ViewRay’s MRIdian MRI-guided Radiotherapy ViewRay Inc. announced that the company’s MRIdian System is the focus of more than 40 abstracts selected by the… read more News | Medical 3-D Printing | August 08, 2019 RSNA and ACR to Collaborate on Landmark Medical 3D Printing Registry The Radiological Society of North America (RSNA) and the American College of Radiology (ACR) will launch a new medical… read more Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al. Technology | Interventional Radiology | August 16, 2019 Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to… read more News | Neuro Imaging | August 16, 2019 ADHD Medication May Affect Brain Development in Children A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s… read more News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor FDA Issues Draft Guidance on Medical Device Safety in MRI Environment The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for… read more center_img News | Magnetic Resonance Imaging (MRI) | September 02, 2015 Swedish Hospital Installs SyMRI Neuro for Improved Follow-up of MS Patients System allows automatic calculation of brain parenchymal fraction via MRI to quantify neurodegeneration News | Stroke | August 16, 2019 Mobile Stroke Unit Gets Patients Quicker Treatment Than Traditional Ambulance Every second counts for stroke patients, as studies show they can lose up to 27 million brain cells per minute…. read more Related Content Feature | Contrast Media | July 18, 2019 | By Greg Freiherr How To Manage Risk in the MR Suite Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n read more Image courtesy of UTHealth McGovern Medical School Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco Technology | Contrast Media | July 15, 2019 FDA Approves Bayer’s Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance… read morelast_img

Leave your comment